Procter & Gamble (NYSE:PG) PT Raised to $165.00 at Raymond James

Procter & Gamble (NYSE:PGGet Rating) had its target price hoisted by research analysts at Raymond James from $155.00 to $165.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ price objective suggests a potential upside of 13.31% from the company’s previous close.

Several other brokerages also recently commented on PG. Barclays lifted their price target on Procter & Gamble from $139.00 to $145.00 and gave the stock an “overweight” rating in a research report on Thursday, October 20th. Wolfe Research assumed coverage on Procter & Gamble in a report on Monday. They set an “outperform” rating and a $156.00 price objective on the stock. Truist Financial decreased their price objective on Procter & Gamble from $175.00 to $160.00 and set a “buy” rating on the stock in a report on Monday, August 1st. Deutsche Bank Aktiengesellschaft lifted their price objective on Procter & Gamble from $155.00 to $156.00 and gave the stock a “buy” rating in a report on Thursday, October 20th. Finally, StockNews.com raised Procter & Gamble from a “hold” rating to a “buy” rating in a report on Thursday, November 17th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $151.00.

Procter & Gamble Stock Up 0.9 %

PG opened at $145.62 on Monday. The business has a 50-day moving average of $133.43 and a 200-day moving average of $140.32. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.62 and a quick ratio of 0.41. Procter & Gamble has a fifty-two week low of $122.18 and a fifty-two week high of $165.35. The company has a market capitalization of $347.38 billion, a PE ratio of 25.24, a price-to-earnings-growth ratio of 4.09 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Rating) last issued its quarterly earnings data on Wednesday, October 19th. The company reported $1.57 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.02. Procter & Gamble had a return on equity of 32.66% and a net margin of 18.11%. The business had revenue of $20.61 billion for the quarter, compared to the consensus estimate of $20.37 billion. During the same period last year, the business earned $1.61 EPS. The firm’s revenue was up 1.3% compared to the same quarter last year. Equities research analysts forecast that Procter & Gamble will post 5.83 EPS for the current fiscal year.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 33,968 shares of the business’s stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total value of $4,668,561.92. Following the completion of the transaction, the chief executive officer now directly owns 38,990 shares of the company’s stock, valued at $5,358,785.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider Mary Theresa Grabowski sold 10,397 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $146.00, for a total transaction of $1,517,962.00. Following the completion of the transaction, the insider now directly owns 4,353 shares of the company’s stock, valued at $635,538. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 33,968 shares of the company’s stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total value of $4,668,561.92. Following the transaction, the chief executive officer now directly owns 38,990 shares of the company’s stock, valued at $5,358,785.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 69,209 shares of company stock worth $9,708,325. 0.26% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Procter & Gamble by 1.0% in the third quarter. Vanguard Group Inc. now owns 224,570,227 shares of the company’s stock valued at $28,351,991,000 after buying an additional 2,197,165 shares during the period. BlackRock Inc. raised its stake in Procter & Gamble by 1.1% in the third quarter. BlackRock Inc. now owns 161,904,833 shares of the company’s stock valued at $20,440,487,000 after buying an additional 1,811,085 shares during the period. State Street Corp raised its stake in Procter & Gamble by 0.8% in the third quarter. State Street Corp now owns 104,749,256 shares of the company’s stock valued at $13,224,594,000 after buying an additional 797,652 shares during the period. Bank of New York Mellon Corp raised its stake in Procter & Gamble by 4.3% in the first quarter. Bank of New York Mellon Corp now owns 23,740,255 shares of the company’s stock valued at $3,627,510,000 after buying an additional 983,197 shares during the period. Finally, Legal & General Group Plc raised its stake in Procter & Gamble by 3.6% in the second quarter. Legal & General Group Plc now owns 18,536,142 shares of the company’s stock valued at $2,665,327,000 after buying an additional 637,095 shares during the period. 63.45% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.